launch lakh biotech export adults cases death recommends icmr company restricted court bharat cost added 612 tablets approved start sii syrup novavax indias active vaccine corbevax study banned dose

Articles for Dcgi, search results for covid

Letter to DCGI seeks emergency use nod for investigational antibiotics to save lives
1 year, 6 months ago

Letter to DCGI seeks emergency use nod for investigational antibiotics to save lives

The Hindu  

Intensivists and infectious diseases specialists, faced with a dire situation where effective antibiotics to treat drug-resistant infections are lacking, have called on the government to allow emergency use authorisation, as successfully done during the COVID-19 pandemic, for certain life-saving drugs. Unfortunately, by the time we receive compassionate use permission to procure investigational antibiotics in phase 3 or licensed antibiotics from …

India Antibiotics Dcgi Eua Ghafur
Covovax to be available on CoWIN as booster dose soon. Check details
1 year, 8 months ago

Covovax to be available on CoWIN as booster dose soon. Check details

Hindustan Times  

In view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion of Serum Institute’s Covovax on the CoWIN portal as a heterologous booster dose for adults, official sources said on Monday. According to an official source, Singh had mentioned in his letter to the ministry that …

India Approved Dcgi Dose Covishield Covovax
DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose
1 year, 11 months ago

DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

News 18  

The Drug Controller General of India has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India, had recently written to the DCGI for the approval …

India Covid Dcgi Sii Covovax Booster Dose Heterologous Booster Dose
Covid News: At High-level Meet, PM Modi Cautions Against Complacency, Advises Increased Tests
2 years ago

Covid News: At High-level Meet, PM Modi Cautions Against Complacency, Advises Increased Tests

News 18  

Covid-19 News Updates: Prime Minister Narendra Modi on Thursday chaired a high-level meeting to review the situation related to Covid-19 in the country and the preparedness of health infrastructure and logistics, the status of the vaccination campaign in the country and the emergence of new Covid-19 variants. The meeting comes a day after Union Health Minister Mansukh Mandaviya reviewed the …

India China Minister Pm Modi Situation Variant Other Countries
SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

India Covid Dcgi Sii Covovax Booster Dose Market Authorisation
Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

India Bharat Biotech
Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots
2 years, 5 months ago

Despite DCGI Nod, Here’s Why Biological E's Corbevax is Not Yet Available for Booster Shots

News 18  

The wait for the roll-out of Biological E’s Corbevax vaccine as a heterologous booster shot may continue for a while, News18.com has learnt. Corbevax was approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India in the first week of June. Thankfully, Omicron does not cause severe disease and hence there is …

Covid Biological Vaccine Strain Omicron Biological E Corbevax
Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use
2 years, 5 months ago

Gennova Biopharmaceuticals' mRNA vaccine gets DCGI approval for emergency use

India TV News  

Highlights GEMCOVAC-19 is the first mRNA vaccine that has been developed in India The company will sell the vaccine under the brand name GEMCOVAC-19 The two-dose vaccine will be administered intramuscularly at 28 days apart India's first indigenously developed mRNA vaccine, GEMCOVAC-19, has been approved for emergency use by the Drug Controller General of India on Tuesday. The vaccine has …

India Pune Vaccine Dcgi Emergency Use Developed Mrna Gennova Biopharmaceuticals
Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years
2 years, 5 months ago

Serum Institute’s Covovax approved by DCGI for children aged 7 to 12 years

Live Mint  

The Serum Institute Of India's Covid-19 vaccine Covovax has been approved on Tuesday by the Drugs Controller General of India for children between the age group of 7 and 12 years. The DCGI's nod for restricted emergency use in children came after the subject expert committee on Covid-19 of the CSDCO last week recommended granting emergency use authorisation to Covovax …

India Vaccination Age Aged Serum 12 Years Dcgi
India's first indigenous mRNA vaccine against Covid gets emergency use nod
2 years, 5 months ago

India's first indigenous mRNA vaccine against Covid gets emergency use nod

India Today  

The Drugs Controller General of India has given a green signal to the country’s first indigenous mRNA vaccine against Covid by Gennova Biopharma for emergency use among adults in India, said sources. While other mRNA vaccines require sub zero temperatures for storage, Gennova Biopharmaceuticals, a Pune-based company, claimed it will not need ultra-cold storages which could mean its roll out …

India Vaccine Mrna Dcgi Gennova Biopharma
Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin
2 years, 6 months ago

Corbevax gets DCGI nod as COVID-19 booster after two doses of Covishield or Covaxin

The Hindu  

Hyderabad-based Biological E. Limited ’s COVID-19 vaccine Corbevax has been approved by the Drug Controller General of India as a heterologous COVID-19 booster dose to individuals aged 18 years and above after 6 months of administration of primary vaccination of Covaxin or Covishield vaccines for restricted use in emergency situations. ‘’Recently, BE furnished its clinical trials data to the DCGI, …

India Vaccine Doses Covishield Corbevax Booster Dose Two Doses
Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above
2 years, 6 months ago

Corbevax Gets DCGI Approval As Covid-19 Vaccine Booster Dose For 18 Years And Above

ABP News  

New Delhi: The Drug Controller General of India approved the Corbevax Covid-19 booster as heterologous Covid-19 booster dose for adults above the age of 18 years who got their primary Covid-19 vaccination of Covishield or Covaxin administered six months before, reported news agency ANI. Recently, BE has furnished its clinical trials data to the DCGI who after a detailed evaluation …

India Covid Booster Dose Corbevax Gets Dcgi
Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose
2 years, 6 months ago

Biological E’s Corbevax gets DCGI nod as heterologous Covid booster dose

Live Mint  

Hyderabad-based pharma company Biological E. Limited on Saturday announced that its Covid-19 vaccine CORBEVAX has been approved by the Drug Controller General of India as a heterologous Covid-19 booster dose for adults. Now, individuals aged 18 years and above who have already taken two doses of either Covishield or Covaxin can now receive a dose of Corbevax as a heterologous …

India Doses Dcgi Omicron Dose Covishield Two Doses
Corbevax gets DCGI nod as Covid-19 booster dose
2 years, 6 months ago

Corbevax gets DCGI nod as Covid-19 booster dose

India TV News  

Highlights Biological E's Corbevax vaccine has been cleared for a booster dose for those 18 and above. The Drugs Controller General Of India had earlier approved Corbevax, India's first indigenously developed RBD protein subunit vaccine, for restricted use in emergency situations for those aged five and above.A press release from the vaccine maker said the Corbevax can be administered as …

India Covid Vaccine Booster Doses Dcgi Dose
SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources
2 years, 7 months ago

SEC seeks more data from Serum Institute of India over COVID vaccine 'Covovax' for 7-12 age group: Sources

India TV News  

Highlights DCGI subject expert committee on April 29 sought more data from SII on Covovax vaccine SEC has sought more data for Covovax vaccine for 7-12 years age group Covovax has already been recommended by DCGI for children above 12 years of age Coronavirus vaccine: The Drugs Controller General of India's subject expert committee on Friday sought more data from …

India Data Age Group Sec Institute Vaccine
India clears 2 vaccines for kids under 12 years
2 years, 7 months ago

India clears 2 vaccines for kids under 12 years

Hindustan Times  

India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children under the age of 12 years – a milestone move that paves the way for that cohort in the country to receive a vaccine shot against the disease for the first time. Currently, Bharat Biotech’s Covaxin, an inactivated …

Children Data National Age Group Approved Vaccine
Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab
2 years, 7 months ago

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

News 18  

In a move that could mitigate the vulnerability of children to the SAR-COV-2 virus, the Drug Controller General of India gave a restricted emergency use authorisation to three vaccines — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D — for various age groups of children. Last week, the expert panel of India’s apex drug regulator recommended grant of …

India Children Age Vaccine Dcgi Bharat Biotech Covaxin
Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children
2 years, 7 months ago

Vaccine for kids: DCGI grants emergency use nod to 3 Covid vaccines for different age group of children

India TV News  

Highlights India began inoculating children aged 12-14 on March 16 Countrywide vaccination drive was rolled out on January 16 last year Precaution doses to all aged above 18 yrs were allowed at private vaccination centres from April 10 Vaccine for Kids: The Drugs Controller General of India on Tuesday approved three Covid vaccines for the restricted emergency use authorisation for …

India Children Emergency Age Group Aged Dcgi
India's drugs regulator approves phase-3 trial of covid vaccine covovax
2 years, 9 months ago

India's drugs regulator approves phase-3 trial of covid vaccine covovax

India Today  

The Drugs Controller General of India granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults, official sources said. The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation had, on March 5, recommended permission for conducting the phase-3 clinical trial for Covovax as a booster dose …

India Covid Vaccine Booster Dcgi Covovax
Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI
2 years, 9 months ago

Gennova Biopharmaceuticals submits Phase 2,3 trial data of India's first mRNA COVID vaccine to DCGI

Firstpost  

The company has also developed an Omicron-specific vaccine which will be tested on humans for efficacy and immunogenicity New Delhi: Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India’s first mRNA COVID vaccine to the regulator Drugs Controller General of India on Friday, said sources. “India is heading towards becoming a vaccine superpower and the fact …

India Covid Vaccine Mrna Other Diseases Gennova Biopharmaceuticals
DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group
2 years, 9 months ago

DCGI Grants Emergency Use Authorisation to SII's Covid Vaccine Covovax for 12-17 Age Group

News 18  

India’s central drug regulator on Wednesday granted emergency use authorisation to Serum Institute of India’s Covid-19 vaccine Covovax for the 12-17 age group subject to certain conditions. Confirming the DCGI approval, Serum Institute of India CEO Adar Poonawalla on Tuesday tweeted:"@SerumInstIndia's brand Covovax has completed bridging studies in India and has been granted Emergency Use Authorisation by DCGI for adults …

India Emergency Age Group Vaccine Dcgi Emergency Use
COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults
2 years, 9 months ago

COVID 19: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adults

India TV News  

Highlights Govt has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax. An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on Sunday. The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation …

India Trial Covid Singh Vaccine Permission Booster
Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose
2 years, 9 months ago

Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose

India Today  

An expert panel of India’s central drug authority has recommended permission to conduct a phase-3 clinical trial of the single-dose Covid-19 vaccine ‘Sputnik Light’ as a booster dose, official sources said on Saturday. "The Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organisation, which reviewed the application on Friday after detailed deliberation, recommended granting permission for the …

India Light Covid Vaccine Dcgi Dose Sputnik
Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group
2 years, 9 months ago

Govt panel recommends granting emergency use authorisation to Covid vaccine Covovax for 12-17 age group

India Today  

An expert panel of the country's central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday. Prakash Kumar Singh, Director-Government and Regulatory Affairs at Serum Institute of India, had submitted an application to the DCGI on February 21, seeking EUA for Covovax for …

India Covid Singh Dcgi Serum Institute Emergency Use Covovax